Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Robotic Pet Company Tombot Secures $6.1M Series A Funding to Support Groundbreaking Health and Senior Care Product Line

    19. Juni 2025

    The Medical Device That’s Become a MAHA Fixation

    19. Juni 2025

    Ash and Impilo Partner to Deliver Seamless At-Home Health Monitoring and Testing Nationwide

    19. Juni 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»Rimidi Partners with Quest Health to Improve Blood Glucose for Diabetes Patients
    News

    Rimidi Partners with Quest Health to Improve Blood Glucose for Diabetes Patients

    HealthradarBy Healthradar19. Juni 2025Keine Kommentare2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Rimidi Partners with Quest Health to Improve Blood Glucose for Diabetes Patients
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Rimidi Partners with Quest Health to Improve Blood Glucose for Diabetes Patients

    What You Should Know: 

    – Quest Health Solutions, a national leader in diabetes care, today announced compelling results from its Remote Patient Monitoring (RPM) program, developed in partnership with the digital health company Rimidi. In just two months, the Quest Health RPM Services—powered by Rimidi’s EHR-integrated platform—led to an 11% improvement in average blood glucose readings among participating patients.

    – The collaboration highlights the power of combining direct-to-patient services with advanced technology to streamline clinical workflows and drive better health outcomes in chronic condition management.

    Clinical Improvements in Early Results

    The partnership has already demonstrated significant clinical impact. In an early cohort of patients using connected Blood Glucose Monitors, the program achieved measurable improvements in glycemic control:

    • Overall average glucose levels dropped by 11%, from 176 mg/dL to 157.5 mg/dL.
    • Morning glucose readings (between 5 a.m. and 9 a.m.) saw an even more significant drop of 16%, from 176 mg/dL to 147.9 mg/dL.
    • These improvements translated to an estimated A1C reduction of approximately 1% for morning readings and 0.7% for overall daily readings.

    A key factor in the program’s success is the seamless integration of Rimidi’s platform into Quest’s athenahealth EHR system. This allows clinical staff to efficiently monitor and manage patients using both cellular-enabled Blood Glucose Monitors and Continuous Glucose Monitors (CGMs). The platform enables risk stratification, customizable alerts, and robust documentation tools that support both clinical decision-making and billing, making the entire RPM process more efficient.

    “Rimidi makes RPM effortless. Our team and partners love the quick access to charting, billing, and patient info — all in one user-friendly platform,” said Jim Klauder, RD, CDCES, LDN, Head of Patient Care at Quest Health RPM Services.

    RPM Offering Expansion Plans

    Quest Health plans to expand its RPM offerings to include support for patients using additional devices, such as blood pressure monitors and pulse oximeters, and to offer its RPM services to healthcare providers across the country.



    Source link

    blood Diabetes Diabetes Management Glucose Health Improve Partners patients Quest Rimidi
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleTrump administration to end 988 suicide prevention specialized service for LGBTQ+ youth in July
    Next Article CharmHealth Innovation Challenge Returns With $10,000 Prize, Spotlights Agentic AI in Healthcare
    ekass777x
    Healthradar
    • Website

    Related Posts

    Gadgets

    Robotic Pet Company Tombot Secures $6.1M Series A Funding to Support Groundbreaking Health and Senior Care Product Line

    19. Juni 2025
    Gadgets

    Ash and Impilo Partner to Deliver Seamless At-Home Health Monitoring and Testing Nationwide

    19. Juni 2025
    News

    Omada Health Data Shows Companion Program Boosts GLP-1 Medication Persistence

    19. Juni 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20257 Views

    Whoop wants everyone to give a whoop about the new Whoop 5.0

    1. Juni 20254 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20254 Views

    Baby Boomers’ Luck Is Running Out

    14. Juni 20253 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20257 Views

    Whoop wants everyone to give a whoop about the new Whoop 5.0

    1. Juni 20254 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.